Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current pharmaceutical design

• Publication date

  2016-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1381612822666160303110838PMID 26935703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.

  2015cited by this paper
• MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway

  2015cited by this paper
• MiR-376a and Histone Deacetylation 9 Form A Regulatory Circuitry in Hepatocellular Carcinoma

  2015cited by this paper
• MiR-15b Targets Cyclin D1 to Regulate Proliferation and Apoptosis in Glioma Cells

  2014cited by this paper
• MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and Suppresses Cell Growth in Hepatocellular Carcinoma Cells

  2014cited by this paper
• Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus

  2014cited by this paper
• Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues

  2014cited by this paper
• MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27.

  2014cited by this paper
• Genome-wide analysis of genetic variations assisted by Ingenuity Pathway Analysis to comprehensively investigate potential genetic targets associated with the progression of hepatocellular carcinoma.

  2014cited by this paper
• Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells.

  2014cited by this paper
• Inhibitions of epithelial to mesenchymal transition and cancer stem cells‐like properties are involved in miR‐148a‐mediated anti‐metastasis of hepatocellular carcinoma

  2014cited by this paper
• MicroRNA‐26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor‐cMet pathway

  2014cited by this paper
• Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.

  2014cited by this paper
• Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells

  2014cited by this paper
• miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs

  2014cited by this paper
• A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus

  2014cited by this paper
• Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.

  2014cited by this paper
• Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy

  2014cited by this paper
• miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7

  2014cited by this paper
• MicroRNA-200a and -200b Mediated Hepatocellular Carcinoma Cell Migration Through the Epithelial to Mesenchymal Transition Markers

  2013cited by this paper
• MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

  2013cited by this paper
• MicroRNA-494 Within an Oncogenic MicroRNA Megacluster Regulates G1/S Transition in Liver Tumorigenesis Through Suppression of Mutated in Colorectal Cancer

  2013cited by this paper
• High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.

  2013cited by this paper
• Circulating microRNAs as a Fingerprint for Liver Cirrhosis

  2013cited by this paper
• MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein*

  2013cited by this paper
• miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma.

  2013cited by this paper
• miRNA profiling of cancer.

  2013cited by this paper
• Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker

  2013cited by this paper
• miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

  2013cited by this paper
• The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis

  2013cited by this paper
• Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.

  2013cited by this paper
• Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.

  2013cited by this paper
• Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET

  2013cited by this paper
• MicroRNA‐10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4‐Mediated epithelial‐mesenchymal transition and adhesion in hepatoma cells *

  2013cited by this paper
• Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5.

  2013cited by this paper
• MicroRNA‐657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin‐like enhancer protein 1 through nuclear factor kappa B pathways

  2013cited by this paper
• miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

  2013cited by this paper
• MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.

  2013cited by this paper
• Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma

  2013cited by this paper
• Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR‐125a‐5p and MiR‐125b

  2013cited by this paper
• MicroRNA‐140‐5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma

  2013cited by this paper
• Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis

  2013cited by this paper
• miR‐148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells

  2013cited by this paper
• Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma

  2013cited by this paper
• miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)*

  2012cited by this paper
• miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma

  2012cited by this paper
• In hepatocellular carcinoma miR‐519d is up‐regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2

  2012cited by this paper
• A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma

  2012cited by this paper
• Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis

  2012cited by this paper
• MicroRNA-520b Inhibits Growth of Hepatoma Cells by Targeting MEKK2 and Cyclin D1

  2012cited by this paper
• Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.

  2012cited by this paper
• Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

  2012cited by this paper
• Liver tumorigenicity promoted by microRNA‐221 in a mouse transgenic model

  2012cited by this paper
• MicroRNA‐7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3‐kinase/Akt pathway in hepatocellular carcinoma

  2012cited by this paper
• miR‐376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma

  2012cited by this paper
• The potential of microRNAs in liver fibrosis.

  2012cited by this paper
• Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening

  2012cited by this paper
• Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

  2012cited by this paper
• Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

  2012cited by this paper
• MiR‐219‐5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican‐3

  2012cited by this paper
• MicroRNA-550a Acts as a Pro-Metastatic Gene and Directly Targets Cytoplasmic Polyadenylation Element-Binding Protein 4 in Hepatocellular Carcinoma

  2012cited by this paper
• Epidemiology of viral hepatitis and hepatocellular carcinoma.

  2012cited by this paper
• Hepatic transforming growth factor beta gives rise to tumor‐initiating cells and promotes liver cancer development

  2012cited by this paper
• Circulating MicroRNAs: Molecular Microsensors in Gastrointestinal Cancer

  2012cited by this paper
• miR‐615‐5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma

  2012cited by this paper
• MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK)

  2012cited by this paper
• MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.

  2012cited by this paper
• Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF

  2012cited by this paper
• Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug‐induced, and inflammatory liver diseases

  2012cited by this paper
• MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.

  2012cited by this paper
• microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.

  2012cited by this paper
• Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.

  2011cited by this paper
• Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

  2011cited by this paper
• MicroRNA‐373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma

  2011cited by this paper
• Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients

  2011cited by this paper
• miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.

  2011cited by this paper
• miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

  2011cited by this paper
• Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance.

  2011cited by this paper
• MicroRNAs in body fluids—the mix of hormones and biomarkers

  2011cited by this paper
• Blood platelets contain tumor-derived RNA biomarkers.

  2011cited by this paper
• Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

  2011cited by this paper
• Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

  2011cited by this paper
• Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.

  2011cited by this paper
• MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

  2011cited by this paper
• Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection

  2011cited by this paper
• DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression*

  2011cited by this paper
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  2011cited by this paper
• MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.

  2011cited by this paper
• The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

  2011cited by this paper
• hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.

  2010cited by this paper
• microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

  2010cited by this paper
• MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.

  2010cited by this paper
• Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

  2010cited by this paper
• miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.

  2010cited by this paper
• MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

  2010cited by this paper
• Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies

  2010cited by this paper
• MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling

  2010cited by this paper
• Deregulation of miR‐92a expression is implicated in hepatocellular carcinoma development

  2010cited by this paper

• Harnessing the connection of the Wnt/beta-catenin pathway and other signaling pathways in glioblastoma multiforme.

  2026cites this paper
• Obstructive sleep apnea and seizures: pathophysiological mechanisms and clinical implications: a narrative review

  2026cites this paper
• MicroRNA Regulation in Cancer: Insights into Diagnosis, Prognosis, and Treatment

  2026cites this paper
• Uncovering molecular signatures and pathogenic pathways in myotonic dystrophy type 1 through bioinformatic analysis

  2026cites this paper
• Nanocarriers for microRNA delivery: A review of applied platforms and perspectives.

  2025cites this paper
• Repurposing ivermectin: a new hope for glioblastoma multiforme?

  2025cites this paper
• miR-221/222, miR-224, and miR-339 are Overexpressed as Potential Biomarkers in Follicular Thyroid Neoplasms

  2025cites this paper
• Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression

  2025cites this paper
• Harnessing the role of insulin-like growth factor in glioblastoma: a comprehensive review.

  2025cites this paper
• Lnc_CXADR/miR-421/ATG7 as promising biomarkers relevant to hepatocellular carcinoma

  2025cites this paper
• Blood circulating miRNAs as pancreatic cancer biomarkers: An evidence from pooled analysis and bioinformatics study.

  2025cites this paper
• Advances in liposome-based delivery of RNA therapeutics for cancer treatment.

  2024cites this paper
• Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease

  2024cites this paper
• MicroRNA delivery by arginine-rich cell-penetrating peptides: An investigation on expression and the cellular uptake mechanisms

  2024cites this paper
• RNA interference-based therapies for atherosclerosis: Recent advances and future prospects.

  2024cites this paper
• Application of RNA-based therapeutics in glioma: A review.

  2024cites this paper
• The Prognostic Value and Clinical Significance of lncRNA SNHG5 Expression in Patients with Multiple Malignancies: A Bioinformatic and Meta-Analysis.

  2024cites this paper
• Gestational Diabetes Mellitus and its Effects on the Developing Cerebellum: A Narrative Review on Experimental Studies

  2024cites this paper
• Advancing gastrointestinal cancer diagnostics: a systematic review and meta-analysis of circulating microRNA-1246 as a non-invasive biomarker

  2024cites this paper
• Blood-based microRNAs as Potential Diagnostic biomarkers for Melanoma: A Meta-analysis.

  2023cites this paper
• Potential roles of circulating microRNAs in the healing of type 1 diabetic wounds treated with green tea extract: molecular and biochemical study

  2023cites this paper
• Prostate cancer and microRNAs: New insights into apoptosis.

  2023cites this paper
• Research Hotspots and Development Trend of microRNA-375 in Hepatocellular Carcinoma—Based on Bibliometric and Visualization Analysis

  2023cites this paper
• Curcumin-based nanomedicines: A promising avenue for brain neoplasm therapy

  2023cites this paper
• Diagnostic accuracy of Tumor M2-Pyruvate Kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysis.

  2023cites this paper
• Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways

  2023cites this paper
• MicroRNA profiles in critically ill patients.

  2023cites this paper
• Emerging roles of ferroptosis-related miRNAs in tumor metastasis

  2023cites this paper
• The key role of microRNA-766 in the cancer development

  2023cites this paper
• Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma

  2022cites this paper
• In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis

  2022cites this paper
• Circulatory microRNAs in helminthiases: Potent as diagnostics biomarker, its potential role and limitations

  2022cites this paper
• Trehalose-induced alterations in serum expression levels of microRNAs associated with vascular inflammation in patients with coronary artery disease - the pilot results from the randomized controlled trial.

  2022cites this paper
• microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway

  2022cites this paper
• Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma

  2022cites this paper
• The promising role and prognostic value of miR-198 in human diseases.

  2022cites this paper
• miRNAs in Cancer (Review of Literature)

  2022cites this paper
• Recent advances in the selection of cancer-specific aptamers for the development of biosensors.

  2022cites this paper
• The role of exosomal miRNA in nonalcoholic fatty liver disease

  2022cites this paper
• Evaluation of miRNA-27a/b expression in patients with familial hypercholesterolemia

  2022cites this paper
• Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation

  2021cites this paper
• A comprehensive review of online resources for microRNA-diseases associations: the state of the art

  2021cites this paper
• MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular Carcinoma

  2021cites this paper
• MicroRNA‐206 has a bright application prospect in the diagnosis of cases with oral cancer

  2021cites this paper
• Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review

  2021cites this paper
• Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma

  2021cites this paper
• Effect of miR‐630 expression on esophageal cancer cell invasion and migration

  2021cites this paper
• Cell death pathways and viruses: Role of microRNAs

  2021cites this paper
• Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression

  2021cites this paper
• The upregulation of microRNA-223 promoted the apoptosis of liver cancer cells via TLR4

  2020cites this paper
• Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network

  2020cites this paper
• microRNA in inflammatory bowel disease at a glance.

  2020cites this paper
• Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis

  2020cites this paper
• Synthesis and biological evaluations of N'-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agents.

  2020cites this paper
• A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs

  2020cites this paper
• Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis

  2020cites this paper
• Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging techniques.

  2020cites this paper
• The neglected nutrigenomics of milk: What is the role of inter-species transfer of small non-coding RNA?

  2020cites this paper
• Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A.

  2020cites this paper
• Long noncoding RNA FOXD2‐AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR‐206/MAP3K1 axis

  2020cites this paper
• Vitamin D and non-coding RNAs: new insights into the regulation of breast cancer.

  2020cites this paper
• CFIm25 in Solid Tumors: Current Research Progress

  2020cites this paper
• Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNAs expression and copy number alterations.

  2020cites this paper
• Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: case report and review of literature

  2020cites this paper
• Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review

  2020cites this paper
• The circular RNA circMAST1 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-1299 and regulating CTNND1 expression

  2020cites this paper
• Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis

  2020cites this paper
• OTT_A_243736 3013..3024

  2020cites this paper
• Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766

  2020cites this paper
• Circulating Cell-Free RNA: A New Perspective for Endometrial Cancer

  2020cites this paper
• miRNAs Signatures In Patients With Acute Liver Injury: Clinical Concerns and Correlations.

  2019cites this paper
• Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis.

  2019cites this paper
• The therapeutic and diagnostic role of exosomes in cardiovascular diseases.

  2019cites this paper
• MicroRNA and exosome: Key players in rheumatoid arthritis

  2019cites this paper
• Knockdown of Sal‐like 4 expression by siRNA induces apoptosis in colorectal cancer

  2019cites this paper
• PPAR‐γ: Its ligand and its regulation by microRNAs

  2019cites this paper
• Circulating microRNA‐133, microRNA‐17 and microRNA‐25 in serum and its potential diagnostic value in gastric cancer

  2019cites this paper
• Modulation of Biological Activities in Glioblastoma Mediated by Curcumin

  2019cites this paper
• Pancreatic β‐cell regeneration: From molecular mechanisms to therapy

  2019cites this paper
• MicroRNAs and response to therapy in leukemia

  2019cites this paper
• Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives

  2019cites this paper
• Circulating MicroRNAs in Cancer: Potential and Challenge

  2019cites this paper
• Role of BCYRN1 in hepatocellular carcinoma pathogenesis by lncRNA-miRNA-mRNA network analysis and its diagnostic and prognostic value.

  2019cites this paper
• MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1

  2019cites this paper
• Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing

  2019cites this paper
• The use of cell free DNA in the diagnosis of HCC

  2019cites this paper
• Inhibition of miRNA-222-3p Relieves Staphylococcal Enterotoxin B-Induced Liver Inflammatory Injury by Upregulating Suppressors of Cytokine Signaling 1

  2019cites this paper
• Cancer stem cells as therapeutic targets of pancreatic cancer

  2019cites this paper
• Liquid biopsies in myeloid malignancies

  2019cites this paper
• OTT_A_230963 11069..11082

  2019cites this paper
• Liver Cancer: Current and Future Trends Using Biomaterials

  2019cites this paper
• miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer

  2019cites this paper
• State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia

  2018cites this paper
• Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome

  2018cites this paper
• Curcumin: A new candidate for retinal disease therapy?

  2018cites this paper
• Molecular aspects of pancreatic β‐cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA

  2018cites this paper
• NLRP3 inflammasome: Its regulation and involvement in atherosclerosis

  2018cites this paper
• MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer

  2018cites this paper
• MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers

  2018cites this paper
• Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers

  2018cites this paper